Breaze Nasal
Product Images NDC 20146-4006

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Breaze Nasal (NDC 20146-4006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Samson Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mL Bottle Carton)

This is a nasal decongestant designed for temporary relief of nasal congestion due to upper respiratory conditions. It works by shrinking swollen nasal membranes so that breathing is made easier. Warnings state that you should not use more than directed, it should not be used for more than three days, it may cause temporary discomfort such as sneezing, burning, and increased nasal discharge. Children under six years old should consult with a doctor before use. The formula for this product includes oxymetazoline HCI, eucalyptus, camphor, and menthol.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.